Topic: Breast cancer
Category: Original article
Materials and Methods: TRPM2 expression analysis was performed using the normalized mRNA expression data downloaded from Broad GDAC Firehose. The functions of TRPM2 in normal and cancer cells are revealed using patch-clamp recording and intracellular calcium imaging techniques.
Results: TRPM2 is expressed at different levels in breast ductal and lobular neoplasm disease between NHB and NHW. Selective knock-down of TRPM2 mRNA with small interfering RNA (siRNA/TRPM2) caused substantial inhibition of cell proliferation of MCF-7(ER+) cells but not in the control human mammary epithelial (HME) cells. The siRNA/TRPM2 also induced cellular apoptosis in MCF-7(ER+) cells but not HME cells. Immunofluorescent staining shows that TRPM2 abnormally localizes in the MCF-7(ER+) nuclei but not HME cells.
Conclusions: These results suggest that TRPM2 is essential in promoting MCF-7(ER+) cell proliferation and may be a potential target for breast cancer treatment.
To cite this article Huang L. P. Immunology & Transplant Science Center, Houston Methodist Research Institute, Houston, TX, USA , Lu Y. Center for Aging, School of Medicine, Tulane University, New Orleans, LA, USA , Li M. Department of Physiology, Tulane University Health Sciences Center, New Orleans, LA, USA WCRJ 2025;
12
: e2870
DOI: 10.32113/wcrj_20255_2870
Submission date: 29 Jul 2024
Revised on: 02 Sep 2024
Accepted on: 23 Dec 2024
Published online: 07 May 2025
Comments (0)